Stay updated on Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial page.

Latest updates to the Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision entry 'Revision: v3.3.3' appears in the record history. The footer links for 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' have been removed.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed from the page history; this is a minor site-versioning detail that does not affect core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedNotice about a lapse in government funding and NIH operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check62 days agoChange DetectedThe screenshots show a minor visual refresh of the Record History page, mainly changes to layout and styling of the version list. No substantive study data or records were altered.SummaryDifference0.1%

- Check91 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference10%

- Check98 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.2%

Stay in the know with updates to Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial page.